White Paper: Pharmacovigilance in HCP social media listening

A guide for Drug Safety professionals, and anybody involved in scoping or approving social media listening projects with healthcare professionals.

Fill out your details below to receive your copy of this Whitepaper for simple tools to inform constructive conversations with your colleagues in market research, or digital marketing, or brand teams, about their social media listening.

Related Resources

20.01.2023 | Article

“What if HCPs leave Twitter?” HCPs flock to Mastodon amid Twitter concerns

There is new trend in eHCP behaviour following the acquisition of Twitter by Elon Musk...

11.01.2023 | Article

The Top Pharma Events in 2023

2023 will see almost 90% of the events within the pharma industry being held in person

By Natalie Verghese

05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma vaccine and immunotherapy

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan

01.01.2023 | Article

Product Launch Tracker: HCPs discuss pre-Christmas approvals in precision medicine, oncology and infectious disease

Discover which new drug approvals HCPs are talking about

By Paul Cranston

18.12.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

In Nov 2022 there was a 22% decrease in HCP pharma mentions from the previous month

By Francesca Gan

16.12.2022 | Article

Product Launch Tracker: HCPs discuss first drug to delay type 1 diabetes and the approval of world’s most expensive treatment

In Nov. 2022 HCPs discussed treatments for multiple myeloma, gene therapy and diabetes.

By Paul Cranston